Literature DB >> 16162481

Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes.

Jenny Ahlqvist1, Julie Fotheringham, Nahid Akhyani, Karen Yao, Anna Fogdell-Hahn, Steven Jacobson.   

Abstract

Human herpesvirus 6 (HHV-6) is a ubiquitous beta -herpesvirus associated with a number of clinical disorders. Two closely but biologically distinct variants have been described. HHV-6 variant B causes the common childhood disease exhanthem subitum, and although the pathologic characteristics for HHV-6 variant A are less well defined, HHV-6A has been suggested to be more neurotropic. We studied the effect of both HHV-6 variants in an oligodendrocyte cell line (MO3.13). Infection of M03.13 was monitored by cytopathic effect (CPE), quantitative TaqMan PCR for viral DNA in cells and supernatant, reverse transcriptase-polymerase chain reaction (RT-PCR) to detect viral RNA, and indirect immunofluorescence (IFA) to detect viral protein expression. HHV-6A infection induced significantly more CPE than infection with HHV-6B. HHV-6B induced an abortive infection associated with a decrease of the initial viral DNA load over time, early RNA expression, and no expression of viral antigen. In contrast, infection with HHV-6A DNA persisted in cells for at least 62 days. During the acute phase of infection with HHV-6A, intracellular and extracellular viral load increased and cells expressed the viral protein IE-2 and gp116/54/64. No HHV-6A RNA or protein was expressed after 30 days post infection, suggesting that HHV-6A formed a latent infection. These studies provide in vitro support to the hypothesis that HHV-6 can actively infect oligodendrocytes. Our results suggest that HHV-6A and HHV-6B have different tropism in MO3.13 cells and that an initially active HHV-6A infection can develop latency. Differences between HHV-6A and -6B infection in different neural cell types may be associated with different neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162481      PMCID: PMC7095087          DOI: 10.1080/13550280591002379

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  61 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis.

Authors:  N Akhyani; R Berti; M B Brennan; S S Soldan; J M Eaton; H F McFarland; S Jacobson
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

3.  Human herpesvirus 6 meningoencephalitis with sequelae.

Authors:  K Yanagihara; K Tanaka-Taya; Y Itagaki; Y Toribe; K Arita; K Yamanishi; S Okada
Journal:  Pediatr Infect Dis J       Date:  1995-03       Impact factor: 2.129

4.  Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient.

Authors:  W R Drobyski; K K Knox; D Majewski; D R Carrigan
Journal:  N Engl J Med       Date:  1994-05-12       Impact factor: 91.245

5.  Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E.

Authors:  N Arbour; S Ekandé; G Côté; C Lachance; F Chagnon; M Tardieu; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  Acute encephalopathy and status epilepticus associated with human herpes virus 6 infection.

Authors:  C M Jones; H G Dunn; E E Thomas; R W Cone; J M Weber
Journal:  Dev Med Child Neurol       Date:  1994-07       Impact factor: 5.449

7.  Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections.

Authors:  D Donati; N Akhyani; A Fogdell-Hahn; C Cermelli; R Cassiani-Ingoni; A Vortmeyer; J D Heiss; P Cogen; W D Gaillard; S Sato; W H Theodore; S Jacobson
Journal:  Neurology       Date:  2003-11-25       Impact factor: 9.910

8.  Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients.

Authors:  S S Soldan; T P Leist; K N Juhng; H F McFarland; S Jacobson
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

9.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

10.  Quantitative analysis of human herpesvirus 6 cell tropism.

Authors:  L De Bolle; J Van Loon; E De Clercq; Lieve Naesens
Journal:  J Med Virol       Date:  2005-01       Impact factor: 2.327

View more
  42 in total

1.  Detection of HHV-6B in post-mortem central nervous system tissue of a post-bone marrow transplant recipient: a multi-virus array analysis.

Authors:  Karen Yao; Nahid Akyani; Donatella Donati; Naomi Sengamalay; Julie Fotheringham; Elodie Ghedin; Michael Bishop; John Barrett; Fatah Kashanchi; Steven Jacobson
Journal:  J Clin Virol       Date:  2006-12       Impact factor: 3.168

2.  The U24 protein from human herpesvirus 6 and 7 affects endocytic recycling.

Authors:  Brian M Sullivan; Laurent Coscoy
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

3.  Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient.

Authors:  Roger E Kelley; Joseph R Berger; Mary Espey; Brian P Kelley
Journal:  J Neurovirol       Date:  2014-11-04       Impact factor: 2.643

4.  Detection frequency of human herpesviruses-6A, -6B, and -7 genomic sequences in central nervous system DNA samples from post-mortem individuals with unspecified encephalopathy.

Authors:  Svetlana Chapenko; Silvija Roga; Sandra Skuja; Santa Rasa; Maksims Cistjakovs; Simons Svirskis; Zane Zaserska; Valerija Groma; Modra Murovska
Journal:  J Neurovirol       Date:  2016-01-04       Impact factor: 2.643

5.  The prevalence of human herpesvirus 6 in human sensory ganglia and its co-occurrence with alpha-herpesviruses.

Authors:  Katharina Hüfner; Viktor Arbusow; Susanne Himmelein; Tobias Derfuss; Inga Sinicina; Michael Strupp; Thomas Brandt; Diethilde Theil
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

Review 6.  Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.

Authors:  M Ogata; T Fukuda; T Teshima
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

7.  Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.

Authors:  Joséphine M Reynaud; Jean-François Jégou; Jérémy C Welsch; Branka Horvat
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

Review 8.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

9.  Interferon beta treatment: bioavailability and antiviral activity in multiple sclerosis patients.

Authors:  Marta Garcia-Montojo; Virginia De Las Heras; Manuel Bartolome; Rafael Arroyo; Roberto Alvarez-Lafuente
Journal:  J Neurovirol       Date:  2007-12       Impact factor: 2.643

10.  Direct Repeat 6 from human herpesvirus-6B encodes a nuclear protein that forms a complex with the viral DNA processivity factor p41.

Authors:  Mariane H Schleimann; Janni M L Møller; Emil Kofod-Olsen; Per Höllsberg
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.